Thus, DAPK1 can be considered as a signaling amplifier of downstream signaling of NR2B subunits at extrasynaptic sites for mediating brain damage in stroke, and targeting NR2B-DAPK1-p53 signaling can be considered as a practical strategy for stroke therapy. The gene discussed is GRIN2B; the disease is Stroke.